Paper - WANFANG MED ONLINE

You Position: Home > Paper

Overexpression or knock-down of runt-related transcription factor 1 affects BCR-ABL-induced proliferation and migration in vitro and leukemogenesis in vivo in mice

( views:113, downloads:16 )

Author:: No author available

Journal Title:: CHINESE MEDICAL JOURNAL

Issue:: 3

DOI:: 10.3760/cma.j.issn.0366-6999.2009.03.018

Key Word:: runt-related transcription factor 1;overexpression;knock-down;proliferation;leukemogenesis

Abstract： Background Runt-related transcription factor 1 (Runx1) plays a crucial role in hematogenesis and its dysfunction may contribute to leukemogenesis. However, it is not clear whether or not abnormal expression of Runx1 will induce leukemia and how the change of Runx1 expression level could affect BCR-ABL-induced leukemogenesis. In the present study, we aimed to analyze if abnormal expression of Runx1 in BaF3 cells alone would induce leukemogenesis. And we also wanted to know if abnormal expression of Runx1 in leukemic cells would affect leukemogenesis. Furthermore, we investigated whether overexpression or knock-down of Runx1 in BaF3 cells would induce leukemogenesis.Methods Plasmids containing full-length Runx1 cDNA were transduced into BaF3 cells and BaF3-P185wt cells (BCR-ABL transformed BaF3 cells) by electroporation. Plasmids containing a short hairpin RNA of Runx1 were transduced into BaF3 cells and BaF3-P185wt cells by electroporation. Runx1 expression level was quantified by Western blotting and quantitative real-time PCR. The effects of overexpression or knock-down of Runx1 on proliferation, apoptosis and migration of cells were detected in vitro. Then, using MSCV-P185wt-FGFP as a control, we transplanted MSCV-P185wt-Runx1 cells or MSCV-P185wt-shRNA cells into Balb/c mice through tail vein and observed tumorgenesis of the different phenotypes.Results In vitro analysis revealed that overexpression of Runx1 in P185wt cells could inhibit cell proliferation and slow down cell migration; while knock-down of Runx1 could promote cell proliferation and speed up cell migration. In vivo analysis indicated that mice transplanted with MSCV-P185wt-Runx1 survived longer than controls. In contrast, mice transplanted with MSCV-P185wt-shRNA survived shorter than the control group. Gross pathological analysis revealed that the MSCV-P185wt-Runx1 group had less severe splenomegaly and hepatomegaly compared to the control group, and the MSCV-P185wt-shRNA group had more severe splenomegaly and hepatomegaly. No splenomegaly or hepatomegaly was detected in mice transplanted with MSCV-BaF3-Runx1 cells or MSCV-BaF3-shRNA cells. Both the mice of MSCV-BaF3-Runx1 group and MSCV-BaF3-shRNA group were healthy with no sign of leukemia for up to three months.Conclusions Overexpression or knock-down of Runx1 gene in BaF3 cells alone could not induce leukemogenesis. However, in BaF3-P185wt cells, alteration of Runx1 expression could affect BCR-ABL-induced proliferation and migration in vitro and leukemogenesis in vivo.

Reference

[1]Qing Wang,Terryl Stacy,Michael Binder.Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis[J].1996,93(8).
[2]Bohlander SK,Gilliland DG,Hiebert SW,etc.Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia.[J].1995,92(11).
[3]Gurbuxani S,Crispino JD,Le-Beau MM,etc.Highly penetrant myeloproliferative disease in the Ts65Dn mouse model of Down syndrome.[J].2008,111(2).
[4]Tsukasa Okuda,Jan van Deursen,Scott W Hiebert,etc.AML1, the Target of Multiple Chromosomal Translocations in Human Leukemia, Is Essential for Normal Fetal Liver Hematopoiesis[J].1996,84(2).
[5]Manuel, Steiner,Andishe, Attarbaschi,Margit, K?nig,etc.Equal frequency of TEL/AML1 rearrangements in children with acute lymphoblastic leukemia with and without Down syndrome.[J].1900,22(3).
[6]Yamashita N,Cao X,Jacob B,etc.Increased dosage of Runx1/AML1 acts as a positive modulator of myeloid leukemogenesis in BXH2 mice.[J].2005,24(28).
[7]Goyama S,Ogawa S,Chiba S,etc.AML1/Runx1 Negatively Regulates Quiescent Hematopoietic Stem Cells in Adult Hematopoiesis.[J].2008,180(7).
[8]Bordigoni P,Bonnet C,Latger-Cannard V,etc.Clinical phenotype of germline RUNX1 haploinsufficiency: from point mutations to large genomic deletions.[J].2008,16(8).
[9]T, Yokomizo,M, Ogawa,M, Osato,etc.Requirement of Runx1/AML1/PEBP2alphaB for the generation of haematopoietic cells from endothelial cells.[J].2001,6(1).
[10]Ahn M.-Y.,Huang G.,Bae S.-C.,etc.Negative regulation of granulocytic differentiation in the myeloid precursor cell line 32Dcl3 by ear-2, a mammalian homolog of Drosophila seven-up, and a chimeric leukemogenic gene, AML1\/ETO(MTG8)[J].1998.
[11]G, Nucifora,J D, Rowley.AML1 and the 8; 21 and 3; 21 translocations in acute and chronic myeloid leukemia.[J].1995,86.
[12]G, Nucifora,C R, Begy,P, Erickson,etc.The 3; 21 translocation in myelodysplasia results in a fusion transcript between the AML1 gene and the gene for EAP, a highly conserved protein associated with the Epstein-Barr virus small RNA EBER 1.[J].1993,90.
[13].A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa Staining[J].1973,243(5405).
[14]Andre Baruchel,Olivier Bernard,Henrik Hasle,etc.Identification of distinct molecular phenotypes in acute megakaryoblastic leukemia by gene expression profiling[J].2006,103(9).
[15]Allen Eng-Juh Yeoh,James R. Downing,Masakazu Higuchi,etc.Alterations of the AML1 transcription factor in human leukemia[J].2000,11(5).
[16]Mitani K.Molecular mechanisms of leukemogenesis by AML1/EVI-1.[J].2004,23(24).
[17]Marin Padilla-M,Howard L,Wang Q,etc.Cbfa2 is required for the formation of intra-aortic hematopoietic clusters.[J].1999,126(11).
[18]Tanaka K,Nishida J,Mitani K,etc.An acute myeloid leukemia gene, AML1, regulates hemopoietic myeloid cell differentiation and transcriptional activation antagonistically by two alternative spliced forms.[J].1995,14(2).
[19]Osato M,Ito Y.Increased dosage of the RUNX1/AML1 gene: a third mode of RUNX leukemia?[J].2005,15(3).
[20]Komatsu N,Matsuura E,Nakata E,etc.RUNX1 suppression induces megakaryocytic differentiation of UT-7/GM cells.[J].2006,345(1).
[21]Miyoshi H.,Shimizu K.,Kozu T.,etc.t(8; 21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1.[J].1991.
[22]Scandura JosephM,Boccuni Piernicola,Cammenga Jorg,etc.Transcription factor fusions in acute leukemia: variations on a theme.[J].2002,21(21).
[23]Okumura AJ,Peterson LF,Okumura F,etc.t(8;21)(q22;q22) Fusion proteins preferentially bind to duplicated AML1/RUNX1 DNA-binding sequences to differentially regulate gene expression.[J].2008,112(4).
[24]Speck NA.Core binding factor and its role in normal hematopoietic development.[J].2001,8(4).
[25]Goyama S,Chiba S,Kurokawa M,etc.AML1-Evi-1 specifically transforms hematopoietic stem cells through fusion of the entire Evi-1 sequence to AML1.[J].2008,22(6).
[26]K, Mitani,S, Ogawa,T, Tanaka,etc.Generation of the AML1-EVI-1 fusion gene in the t(3; 21)(q26; q22) causes blastic crisis in chronic myelocytic leukemia.[J].1994,13.